CD40LG and COVID-19: Demographic characteristics of the sample that included 709 individuals who were tested for SARS-CoV-2 antibodies using the BioMedomics COVID-19 IgM/IgG Rapid Test and the Roche Elecsys Anti-SARS-CoV-2 assay.